After the clonal selection of resistant tumor cells, IFN-γ signaling was abrogated in two patients due to the loss of JAK1 or JAK2 kinases, and, in one patient, the gene encoding β2-microglobulin was truncated, which led to the elimination of surface MHC-I expression. The gene discussed is IFNG; the disease is neoplasm.